• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Life Sciences Partners

Neuravi raises $21m Series B for thrombectomy device

June 17, 2015 By Fink Densford

Neuravi said today that it raised $21 million in a Series B  round for its Embotrap minimally invasive thrombectomy device. “The intention of the funding round is to launch the device in Europe, to run the Arise program for the U.S., to attempt to bring the device for U.S. approval and to continue to develop further […]

Filed Under: Blood Management, Business/Financial News, Cardiovascular, Catheters, Stents Tagged With: Life Sciences Partners, Neuravi Limited

Direct Flow Medical raises a $32 million in funding round | Medtech funding for the week of December 1, 2014

December 5, 2014 By MassDevice Contributors Network Leave a Comment

TAVI: Direct Flow Medical raises $32m, names 1st CCO

December 3, 2014 by Brad Perriello

Filed Under: Funding Roundup, News Well Tagged With: Ally Bridge Group, BioStar Ventures, Blue Sky Fund, Blue Stem Capital, Conventus Orthopaedics, Covidien, Deerfield Management, Direct Flow Medical Inc., Kurma Partners, Life Sciences Partners, PDL BioPharma, Sightline Partners, Spray Fund, SV Life Sciences, VI Partners, Xeltis

Xeltis raises $34m for regenerative heart valve tech

December 2, 2014 By Brad Perriello

Xeltis raises $34m for regenerative heart valve tech

Xeltis said today that it closed an over-subscribed Series B round worth about $34 billion for the regenerative heart valve technology it’s developing.

Filed Under: Funding Roundup, News Well, Regenerative Medicine, Replacement Heart Valves Tagged With: Kurma Partners, Life Sciences Partners, VI Partners, Xeltis

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy